At a glance
- Originator Nonindustrial source
- Class Antihypertensives; Aporphines; Small molecules
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 18 Nov 1998 No-Development-Reported for Hypertension in USA (Unknown route)
- 30 Apr 1996 New profile
- 30 Apr 1996 Preclinical development for Hypertension in USA (Unknown route)